Article

Dynamic IOP measurements track changes during phaco

A comparison of dynamic IOP values during cataract extraction by phacoemulsification using high and low flow found that lower bottle heights result in lower fluctuations of IOP. An enhanced fluidics management system allows the use of a lower bottle height with concomitant use of high vacuum and aspiration flow rate, without compromising the stability of the anterior chamber.

Key Points

San Diego-A comparison of dynamic IOP values during cataract extraction by phacoemulsification using high and low flow found that lower bottle heights result in lower fluctuations of IOP, according to Abhay Vasavada, MS, FRCS.

"IOP measurements provide information to help better understand fluid dynamics during phacoemulsification. IOP is dependent on irrigation fluid input and output, and it is important to maintain a balance between infusion and aspiration parameters to reduce IOP fluctuations," Dr. Vasavada explained, emphasizing the clinical relevance of IOP measurements. He is director, Iladevi Cataract & IOL Research Centre and chief, Raghudeep Eye Clinic, Ahmedabad, India.

The IOP values were measured using a sensor attached to a pressure transducer. Measurements from the oscilloscope were overlaid as graphs onto the surgical video-observable in real time on a viewing monitor-and recorded.

Sixty patients were divided into one of the six following groups of 10 patients each:

Dr. Vasavada explained that the enhanced fluidics management system had the same cassette design as the currently used one with one difference: more stiff aspiration tubing to reduce surge. IOP measurements were monitored continuously during the sculpting, nuclear division, and fragment removal.

With low fluidics, a vacuum rate of up to 400 mm Hg, aspiration flow rate of 25 ml/min, and bottle height of 70 to 90 cm were used; with high fluidics, the vacuum was set up to 650+ mm Hg, the aspiration flow rate was 40 ml/min, and the bottle height was 90 to 110 cm.

All patients underwent microcoaxial phacoemulsification using a 2.2-mm incision and longitudinal ultrasound (ultrasound power, 60%; microbursts, 20 milliseconds).

He reported that in group 1, in which the current fluidics management system was used with low fluidics, the maximum and minimum IOP values were 75 and 46 mm Hg, respectively. In group 2, with the current fluidics management system and high fluidics, the IOP values were 79 and 38 mm Hg; in group 3, with the enhanced fluidics management system and low fluidics, 72 and 41 mm Hg; in group 4, with the enhanced fluidics management system with high fluidics, 81 and 39 mm Hg; in group 5, with the current fluidics management system and high fluidics with a low bottle height, 82 and 34 mm Hg; and in group 6, with the enhanced fluidics management system, high fluidics, and low bottle height, 75 and 40 mm Hg.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.